Source: Investing.com ↗

Tyra Biosciences stock tumbles 30% on phase 2 trial results

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.00%

BTC/USDT

$66,928.01

-3.08%

ETH/USDT

$1,889.36

-3.06%

SOL/USDT

$75.33

-4.39%

ZEC/USDT

$916.08

-2.11%